Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
 arrow  PDF of this article
(PDFs free after 6 months)
space
 arrow  Figures/Tables List
space
 arrow  Related articles in Annals
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box PubMed
Articles in PubMed by Author:
  arrow  Anthonisen, N. R.
space
 arrow  PubMed                        
space

REPLY

The Effects of a Smoking Cessation Intervention on 14.5-Year Mortality

right arrow Nicholas R. Anthonisen, MD

18 October 2005 | Volume 143 Issue 8 | Page 615


IN RESPONSE:

Dr. Mathew rightly points out that the Lung Health Study smoking cessation program was accompanied by the prescription of inhalers and believes that we may not have given them adequate consideration. He agrees that the content of the inhalers (placebo or bronchodilator) did not make a difference and appears to accept that it was differences in smoking habits that determined the improved survival in the special intervention group. It therefore follows that if the inhalers were important, it was because they made the smoking cessation program more effective. Maybe so, but we are unapologetic about attributing the smoking cessation largely to the program we designed to induce it. Inhalers themselves probably have little to no effect on smoking habits, as evidenced by the fact that smoking rates are about as high in persons with asthma as they are in the general population (1, 2).

Dr. Bombassei is interested in Kaplan–Meier survival curves in Lung Health Study participants who quit smoking compared with those who did not. In our paper, we indicated that mortality was 6.04 per 1000 person-years in sustained quitters, 7.77 per 1000 person-years in intermittent quitters, and 11.09 per 1000 person-years in continuing smokers. We append the appropriate Figure.



View larger version (24K):
[in this window]
[in a new window]
 
Figure. All-cause 14.5-year survival in the Lung Health Study (LHS). Four hundred eighty-five of 3322 (14.6%) patients died in the continuing smoker group versus 168 of 1607 (10.5%) in the intermittent quitter group and 78 of 958 (8.1%) in the sustained quitter group (P < 0.001 [log-rank test]).

 


Author and Article Information
space
up arrowTop
dotAuthor & Article Info
down arrowReferences

From University of Manitoba, Winnipeg, Manitoba R3A 1R8, Canada.


References
space
up arrowTop
up arrowAuthor & Article Info
dotReferences

1. Higenbottam TW, Feyeraband C, Clark TJ. Cigarette smoking in asthma. Br J Dis Chest. 1980;74:279-84. [PMID: 7426367].[Medline]

2. Silverman RA, Boudreaux ED, Woodruff PG, Clark S, Camargo CA Jr. Cigarette smoking among asthmatic adults presenting to 64 emergency departments. Chest. 2003;123:1472-9. [PMID: 12740263].[Abstract/Free Full Text]

About Letters
space

The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:

•Include no more than 300 words of text, three authors, and five references

•Type with double-spacing

•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.

Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.

Annals welcomes electronically submitted letters.


Related articles in Annals:

Articles
The Effects of a Smoking Cessation Intervention on 14.5-Year Mortality: A Randomized Clinical Trial
Nicholas R. Anthonisen, Melissa A. Skeans, Robert A. Wise, Jure Manfreda, Richard E. Kanner, John E. Connett, AND for the Lung Health Study Research Group*
Annals 2005 142: 233-239. [ABSTRACT][SUMMARY][Full Text]  

Letters
The Effects of a Smoking Cessation Intervention on 14.5-Year Mortality
Milan C. Mathew
Annals 2005 143: 614-615. [Full Text]  

Letters
The Effects of a Smoking Cessation Intervention on 14.5-Year Mortality
Gregory J. Bombassei
Annals 2005 143: 615. [Full Text]  




box Article
 arrow  Table of Contents                
space
 arrow  PDF of this article
(PDFs free after 6 months)
space
 arrow  Figures/Tables List
space
 arrow  Related articles in Annals
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box PubMed
Articles in PubMed by Author:
  arrow  Anthonisen, N. R.
space
 arrow  PubMed                        
space


 Home | Current Issue | Past Issues | Audio/Video | CME | Collections | In the Clinic | Mobile | Subscribe | Tools | Help | ACP Online